Bruno Silva Santo

Bruno Silva Santo is a prominent researcher in the field of immunotherapy, particularly known for his work on the innovative DOT cell therapy aimed at treating colorectal cancer. As a co-author of a groundbreaking study published in Nature Cancer, he contributed to demonstrating the efficacy of this therapy, which enhances the power of specific white blood cells to target and eliminate tumors. His research, conducted at the Gulbenkian Institute of Molecular Medicine in Lisbon, has been pivotal in developing potential treatments that could significantly improve outcomes for patients with colorectal cancer, one of the most common and lethal cancers in Spain.